Journal Of Clinical Oncology (jco) Podcast
Risky Business: PD-1 Immune Checkpoint Blockade in Thymic Epithelial Neoplasms
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:08:40
- More information
Informações:
Synopsis
This podcast discusses the important risks and potential benefits of PD-1 immune checkpoint blockade in patients with thymic epithelial neoplasms. Read the related article "Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial" on JCO.org